Navigation Links
Fingerprints May Vanish With Cancer Drug
Date:5/27/2009

Travelers are warned of side effect that could hamper immigration checks

WEDNESDAY, May 27 (HealthDay News) -- The widely used cancer drug capecitabine can cause people to lose their fingerprints, which could lead to problems when they're trying to enter the United States, an oncologist warns.

Dr. Eng-Huat Tan, a senior consultant in medical oncology at the National Cancer Centre in Singapore, said he now advises people taking capecitabine to carry a doctor's letter when traveling.

In a letter published online Wednesday in the Annals of Oncology, Tan described the experience of a 62-year-old cancer patient taking capecitabine who was held for four hours by U.S. immigration officials because his fingerprints had vanished. The man was eventually allowed into the country.

Tan said that several other cancer patients have reported the loss of fingerprints on their blog sites and some have also said they've had problems entering the United States.

Capecitabine -- used to treat head and neck cancers, breast, stomach and colorectal cancers, among others -- can cause a side effect called hand-foot syndrome. This is a chronic inflammation of the palms of the hands or soles of the feet that can cause the skin to peel, bleed and develop ulcers or blisters, Tan said.

"This can give rise to eradication of fingerprints with time," he explained.

"In summary, patients taking long-term capecitabine may have problems with regards to fingerprint identification when they enter the United States' ports or other countries that require fingerprint identification and should be warned about this," Tan wrote.

"It is uncertain when the onset of fingerprint loss will take place in susceptible patients who are taking capecitabine," Tan said. "However, it is possible that there may be a growing number of such patients as 'Mr. S.' who may benefit from maintenance capecitabine for disseminated malignancy. These patients should prepare adequately before traveling to avert the inconvenience that 'Mr. S.' was put through."

Tan recommended that people taking capecitabine carry a letter from their oncologist.

"My patient subsequently traveled again with a letter from us, and he had fewer problems getting through" immigration, Tan said.

More information

The U.S. National Library of Medicine has more about capecitabine.



-- Robert Preidt



SOURCE: Annals of Oncology, news release, May 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer drug causes patient to lose fingerprints and be detained by US immigration
2. DNA Fingerprints Predict Brain Disorders
3. Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
4. Berkeley Lab scientist co-leads breast cancer dream team
5. $18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
6. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
7. Gene Mutation May Up Risks of Endometrial Cancer
8. U.S. Cancer Death Rates Continue to Fall
9. Hanes(R) Teams up with Susan G. Komen for the Cure(R) and Actress Sarah Chalke to Comfort Those Affected by Breast Cancer
10. Predicting higher risk for prostate cancer diagnosis
11. Risks Remain for Childhood Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fingerprints May Vanish With Cancer Drug
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has ... the Atlanta Football Host Committee (AFHC) for the 2018 College ... Jan. 8, 2018, at Mercedes-Benz Stadium in Atlanta, ... of the AFHC "I,m In" campaign, participating in many activities ... ...
Breaking Medicine Technology: